FDA authorizes generic Trileptal versions

10/10/2007 | CNNMoney · Bloomberg1

The FDA will allow three generic drugmakers to launch their versions of Novartis AG's epilepsy treatment Trileptal. Boehringer Ingelheim subsidiary Roxane Laboratories, Glenmark Pharmaceuticals Ltd. and Sun Pharmaceutical Industries Ltd. received FDA approval.

View Full Article in:

CNNMoney · Bloomberg1

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX